10/09/2009
print this
article | 
email article to a friend
Professor David Reid (University of Aberdeen) has raised concerns over the licensing of osteoporosis drugs by the National Institute for Health and Clinical Excellence (NICE). Professor Reid delivered a lecture on the treatment of osteoporosis during the British Science Festival at an event organised by the Society for Endocrinology and National Osteoporosis Society.
Full article
Link:
http://www.bioscinews.co.uk/article.aspx?articleid=1664
BioSci Contact:
Jo Thurston
News Source:
Categories:
Endocrinology
|
European
|